Survival outcomes with oral azacitidine maintenance in patients with acute myeloid leukemia in remission by receipt of initial chemotherapy: subgroup analyses from the phase 3 QUAZAR AML-001 trial. Academic Article uri icon

Overview

abstract

  • Not available.

authors

  • Wei, Andrew H
  • Roboz, Gail J
  • Dombret, Herve
  • Dohner, Hartmut
  • Schuh, Andre C
  • Montesinos, Pau
  • Selleslag, Dominik
  • Bondarenko, Sergey N
  • Prebet, Thomas
  • Lai, Yinzhi
  • Skikne, Barry
  • Beach, C L
  • Ravandi, Farhad

publication date

  • March 23, 2023

Identity

Digital Object Identifier (DOI)

  • 10.3324/haematol.2022.282296

PubMed ID

  • 36951156